Why is urinalysis done in diagnosing Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urinalysis in the Diagnosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

Urinalysis is performed in SJS/TEN diagnosis primarily to detect urogenital tract involvement and monitor for complications, as urinary dysfunction is common during the acute phase of the disease.

Role of Urinalysis in SJS/TEN Diagnosis and Management

Detecting Urogenital Involvement

  • Urogenital tract involvement is characterized by mucosal erythema, blistering, and erosions 1
  • During the acute phase, pain is prominent and urinary dysfunction (dysuria or retention) is common 1
  • Urinalysis helps detect:
    • Blood in urine (hematuria) from mucosal erosions
    • Signs of infection (bacteria, white blood cells)
    • Protein in urine (proteinuria) from inflammation

Monitoring for Complications

  • Secondary infection by bacteria or candida is a frequent complication of urogenital involvement 1
  • Herpes simplex virus (HSV) activation may also occur and can be detected through appropriate testing 1
  • Urinalysis helps monitor for:
    • Urinary tract infections
    • Renal complications
    • Systemic complications affecting urinary output

Clinical Significance of Urogenital Involvement

Acute Phase Management

  • Catheterization is recommended for all patients to prevent strictures forming in the urethra 1
  • Regular examination of the urogenital tract is necessary as part of the initial assessment and throughout the acute illness 1
  • Daily documented urogenital review is necessary during the acute illness 1

Long-term Complications

  • Erosions of the genital mucosae may persist for many weeks after the acute phase has resolved, ultimately healing with scarring 1
  • Serious morbidity can ensue in the form of:
    • Strictures and stenosis of the urethra
    • Phimosis in males
    • Vaginal synechiae in females
    • Resultant urinary and sexual dysfunction 1

Management of Urogenital Involvement

Topical Therapy

  • Apply white soft paraffin ointment to the urogenital skin and mucosae immediately and thereafter every 4 hours through the acute illness 1
  • Use Mepitel dressings to eroded areas in the vulva and vagina to reduce pain and prevent adhesions 1
  • Consider applying a potent topical corticosteroid ointment once daily to the involved, non-eroded, urogenital surfaces 1

Follow-up Considerations

  • Patients should be informed about potential long-term urogenital problems during discharge planning 1
  • Follow-up with appropriate specialists is necessary to manage potential urogenital complications 2

Common Pitfalls and Caveats

  1. Overlooking urogenital involvement: Urogenital examination should be part of the initial assessment and ongoing monitoring in all SJS/TEN patients 1

  2. Failure to catheterize: All patients should be catheterized to prevent urethral strictures 1

  3. Inadequate monitoring: Daily documented urogenital review is necessary during the acute illness 1

  4. Neglecting gender-specific care:

    • In women, early assessment by a vulval specialist is recommended for consideration of dilators to prevent vaginal synechiae 1
    • Uncircumcised male patients should be checked for preputial retractability 1
  5. Missing long-term complications: Urogenital problems should be discussed as potential long-term issues during discharge planning 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.